MARKET

OXFD

OXFD

Oxford Immunotec
NASDAQ

Real-time Quotes | Nasdaq Last Sale

9.92
+0.03
+0.30%
After Hours: 9.92 0 0.00% 16:00 03/27 EDT
OPEN
9.66
PREV CLOSE
9.89
HIGH
10.12
LOW
9.07
VOLUME
121.62K
TURNOVER
--
52 WEEK HIGH
17.77
52 WEEK LOW
8.37
MARKET CAP
259.96M
P/E (TTM)
-191.1368
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of OXFD and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average OXFD stock price target is 20.33 with a high estimate of 21.00 and a low estimate of 20.00.

EPS

OXFD News

More
  • Edited Transcript of OXFD earnings conference call or presentation 2-Mar-20 1:00pm GMT
  • Thomson Reuters StreetEvents · 5d ago
  • The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment
  • Benzinga · 03/17 15:38
  • The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings
  • Benzinga · 03/13 11:52
  • Investors Who Bought Oxford Immunotec Global (NASDAQ:OXFD) Shares A Year Ago Are Now Down 22%
  • Simply Wall St. · 03/09 20:57

Industry

Advanced Medical Equipment & Technology
-2.20%
Healthcare Equipment & Supplies
-1.86%

Hot Stocks

Symbol
Price
%Change

About OXFD

Oxford Immunotec Global PLC,is a diagnostics company. It is focused on developing and commercializing tests for under-served immune-regulated conditions. Its product lines and development activities principally focus on four areas: infectious diseases, transplantation, autoimmune and inflammatory disease and immune-oncology. It offers a range of assays for tick-borne diseases, such as Lyme disease, obtained through the acquisitions of Imugen and Immunetics. Tick-borne disease is the collective name for diseases passed to humans through the bite of an infected tick. Its diagnostic tests for tick-borne infections include multiple laboratory developed tests (LDTs). Its tick-borne disease tests utilize molecular methods (such as polymerase chain reaction) and techniques to prosecute the immune system. It has a series of assays for use in blood screening, building upon its expertise in tick-borne disease.
More

Webull offers kinds of Oxford Immunotec Global PLC stock information, including NASDAQ:OXFD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OXFD stock news, and many more online research tools to help you make informed decisions.